DK3649260T3 - Target-beriget multiplekset parallel analyse til vurdering af tumorbiomarkører - Google Patents

Target-beriget multiplekset parallel analyse til vurdering af tumorbiomarkører Download PDF

Info

Publication number
DK3649260T3
DK3649260T3 DK18745511.8T DK18745511T DK3649260T3 DK 3649260 T3 DK3649260 T3 DK 3649260T3 DK 18745511 T DK18745511 T DK 18745511T DK 3649260 T3 DK3649260 T3 DK 3649260T3
Authority
DK
Denmark
Prior art keywords
vurdering
tumorbiomarkører
multiplekset
beriget
til
Prior art date
Application number
DK18745511.8T
Other languages
English (en)
Inventor
George Koumbaris
Marios Ioannides
Elena KYPRI
Acilleas Achilleos
Petros MINA
Alexia Eliades
Charalambos Loizides
Philippos Patsalis
Original Assignee
Nipd Genetics Public Company Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nipd Genetics Public Company Ltd filed Critical Nipd Genetics Public Company Ltd
Application granted granted Critical
Publication of DK3649260T3 publication Critical patent/DK3649260T3/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6876Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
    • C12Q1/6883Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
    • C12Q1/6886Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6806Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Analytical Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Genetics & Genomics (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • Biochemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • General Health & Medical Sciences (AREA)
  • Pathology (AREA)
  • Hospice & Palliative Care (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Apparatus For Radiation Diagnosis (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
DK18745511.8T 2017-07-07 2018-07-06 Target-beriget multiplekset parallel analyse til vurdering af tumorbiomarkører DK3649260T3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762529779P 2017-07-07 2017-07-07
PCT/EP2018/068441 WO2019008172A1 (en) 2017-07-07 2018-07-06 ENRICHED MULTIPLEXED PARALLEL ANALYSIS IN TARGET FOR TUMOR BIOMARKER EVALUATION

Publications (1)

Publication Number Publication Date
DK3649260T3 true DK3649260T3 (en) 2022-08-08

Family

ID=63012987

Family Applications (1)

Application Number Title Priority Date Filing Date
DK18745511.8T DK3649260T3 (en) 2017-07-07 2018-07-06 Target-beriget multiplekset parallel analyse til vurdering af tumorbiomarkører

Country Status (11)

Country Link
US (2) US12435374B2 (da)
EP (2) EP4095258B1 (da)
AU (2) AU2018298443B2 (da)
CA (1) CA3068122A1 (da)
CY (1) CY1125388T1 (da)
DK (1) DK3649260T3 (da)
ES (1) ES2924548T3 (da)
PL (1) PL3649260T3 (da)
PT (1) PT3649260T (da)
WO (1) WO2019008172A1 (da)
ZA (1) ZA201908559B (da)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SI3371171T1 (sl) 2015-11-02 2024-03-29 Blueprint Medicines Corporation Inhibitorji ret
PE20210096A1 (es) 2018-04-03 2021-01-12 Blueprint Medicines Corp Inhibidor de ret para uso en tratar cancer que tiene una alteracion de ret
EP3833372A4 (en) 2018-08-10 2022-06-08 Blueprint Medicines Corporation TREATMENT OF EGFR MUTANT CANCER
EP4157829A1 (en) 2020-05-29 2023-04-05 Blueprint Medicines Corporation Solid forms of pralsetinib
BE1029144B1 (fr) 2021-02-25 2022-09-20 Oncodna Méthode de caracterisation d'une tumeur à l'aide d'un séquençage ciblé
CN117524304B (zh) * 2024-01-08 2024-03-29 北京求臻医学检验实验室有限公司 实体瘤微小病灶残留的检测panel、探针组及其应用
WO2025228816A1 (en) * 2024-05-02 2025-11-06 Medicover Biotech Ltd Method of targeted sequencing for diagnosis

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3591068A1 (en) 2006-02-02 2020-01-08 The Board of Trustees of the Leland Stanford Junior University Non-invasive fetal genetic screening by digital analysis
US20080194414A1 (en) * 2006-04-24 2008-08-14 Albert Thomas J Enrichment and sequence analysis of genomic regions
WO2008027548A2 (en) * 2006-09-01 2008-03-06 Dana-Farber Cancer Institute, Inc. Microarray-based global chromatin structure mapping
CA3069082C (en) 2008-09-20 2022-03-22 The Board Of Trustees Of The Leland Stanford Junior University Noninvasive diagnosis of fetal aneuploidy by sequencing
US20110039304A1 (en) * 2009-08-12 2011-02-17 President And Fellows Of Harvard College Methods to Generate Oligonucleotide Pools and Enrich Target Nucleic Acid Sequences
CA2780827A1 (en) * 2009-12-31 2011-07-07 Ventana Medical Systems, Inc. Methods for producing uniquely specific nucleic acid probes
US20120270739A1 (en) 2010-01-19 2012-10-25 Verinata Health, Inc. Method for sample analysis of aneuploidies in maternal samples
EP2370599B1 (en) 2010-01-19 2015-01-21 Verinata Health, Inc Method for determining copy number variations
US20130123120A1 (en) 2010-05-18 2013-05-16 Natera, Inc. Highly Multiplex PCR Methods and Compositions
KR102759126B1 (ko) * 2010-12-30 2025-01-24 파운데이션 메디신 인코포레이티드 종양 샘플의 다유전자 분석의 최적화
EP3187597B1 (en) 2011-02-09 2020-06-03 Natera, Inc. Methods for non-invasive prenatal ploidy calling
EP2959016A4 (en) * 2013-02-21 2016-10-12 Toma Biosciences Inc METHOD, COMPOSITIONS AND NUCLEIC ACID ANALYSIS KITS
US20150203907A1 (en) * 2014-01-17 2015-07-23 Florida State University Research Foundation Genome capture and sequencing to determine genome-wide copy number variation
GB201414451D0 (en) 2014-08-14 2014-10-01 Oxford Gene Technology Operations Ltd Hybridisation column for nucleic acid enrichment
WO2016040446A1 (en) 2014-09-10 2016-03-17 Good Start Genetics, Inc. Methods for selectively suppressing non-target sequences
EP3666902B1 (en) 2015-05-22 2024-07-03 Medicover Public Co Ltd Multiplexed parallel analysis of targeted genomic regions for non-invasive prenatal testing
PT3649258T (pt) 2017-07-07 2022-05-25 Nipd Genetics Public Company Ltd Análise paralela multiplexada enriquecida com alvo para avaliação de amostras de adn fetal
ES2920280T3 (es) 2017-07-07 2022-08-02 Nipd Genetics Public Company Ltd Enriquecimiento de regiones genómicas blanco para análisis paralelo multiplexado

Also Published As

Publication number Publication date
US20250115965A1 (en) 2025-04-10
EP3649260A1 (en) 2020-05-13
CY1125388T1 (el) 2024-09-20
PL3649260T3 (pl) 2022-10-17
PT3649260T (pt) 2022-05-30
AU2025200522A1 (en) 2025-04-10
EP4095258A1 (en) 2022-11-30
WO2019008172A1 (en) 2019-01-10
ZA201908559B (en) 2022-07-27
ES2924548T3 (es) 2022-10-07
EP3649260B1 (en) 2022-05-11
CA3068122A1 (en) 2019-01-10
US20220228219A1 (en) 2022-07-21
AU2018298443B2 (en) 2024-11-21
US12435374B2 (en) 2025-10-07
EP4095258B1 (en) 2026-04-29
AU2018298443A1 (en) 2020-01-16

Similar Documents

Publication Publication Date Title
DK3783479T3 (en) Optimeret computerhardware til maskinlæringsoperationer
DK3334828T3 (en) Fremgangsmåde til at øge replikationen af et cirkulært dna-molekyle
DK3440128T3 (en) Recirkulation af polymermatrixkompositmateriale
DK3827838T5 (en) Hæmning af cytokin-induceret sh2-protein i nk-celler
DK3499914T3 (en) Høreapparatsystem
DK3509582T3 (en) Solvatform af (r)-2-amino-3-phenylpropylcarbamat
DK3645518T3 (en) Syntese af omecamtiv mecarbil
DK3700925T3 (en) Hidtil ukendt t-cellereceptor
DK3649260T3 (en) Target-beriget multiplekset parallel analyse til vurdering af tumorbiomarkører
DK3276086T3 (en) Gravitationsfundament til installation af havvindmøller
DK3456957T3 (en) Modvægtssystem til balanceret navvindmølleinstallation
ZA202001147B (en) Construction component
GB201820521D0 (en) n
DK3372911T3 (en) Integration af laboratorieventilation
DK3726976T3 (en) Klimareguleringssystem til insektopdræt
DK3359556T3 (en) Modulering af gamma-c-cytokinaktivitet
DK3449331T3 (en) Indretning til at styre fluidstrømning
GB201701986D0 (en) n
GB201713562D0 (en) Trap
GB201710348D0 (en) Sub-realms
DK3723826T3 (en) Anordning til styring af et medicinregime
DK3612289T3 (en) Apparat til katalytisk nedbrydning af dinitrogenoxid i en gasstrøm
GB201813378D0 (en) n
GB201722178D0 (en) Y
PL3401453T3 (pl) Syfon